<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02393274</url>
  </required_header>
  <id_info>
    <org_study_id>201412045RINA</org_study_id>
    <nct_id>NCT02393274</nct_id>
  </id_info>
  <brief_title>Microcirculation in Venoarterial Extracorporeal Membrane Oxygenation Life Support</brief_title>
  <official_title>Investigation of Microcirculation in Patients With Venoarterial Extracorporeal Membrane Oxygenation Life Support</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>National Taiwan University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>National Taiwan University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Extra-corporeal membrane oxygenation (ECMO) life support system can provide both cardiac and&#xD;
      respiratory support to patients with heart and respiratory failure. It can save time for&#xD;
      these organs to recovery or for these patients to receive further management. However, many&#xD;
      patients will die in spite of ECMO support. One of the key factor is whether the blood flow&#xD;
      provided by the ECMO can meet the requirement of organ perfusion. The adequacy of&#xD;
      macrocirculation may be determined by arterial pressure and minute blood flow of ECMO.&#xD;
      However, the adequacy of microcirculation remains as a major unresolved clinical problem.&#xD;
      This is a prospective observational clinical trial. The sublingual microcirculation will be&#xD;
      examined with the incident dark field video microscope within 6 hours after venoarterial ECMO&#xD;
      placement, and then at 24 h, 48 h, 72 h, and 96 h. The severity of multiple organ injury and&#xD;
      clinical data will be recorded as well. The major parameters of microcirculation include&#xD;
      total small vessel density, perfused small vessel density, and microvascular flow index. The&#xD;
      sublingual microcirculation will also be examined before weaning off ECMO, within 6 hours&#xD;
      after ECMO removal, and then at 24 h, 48 h, and 72 h. Serum level of endothelial cell&#xD;
      specific molecule-1 at specific time points will be examined. The data of 14-day mortality,&#xD;
      28-day mortality, duration of ECMO support, and intensive care unit stay will be recorded.&#xD;
      This study aims primarily to investigate the relationship between microcirculation and&#xD;
      prognosis of these patients. This study will also investigate the relationship among serum&#xD;
      level of endothelial cell specific molecule-1, microcirculation, and prognosis of these&#xD;
      patients. Wish the results of this study can be applied in further research to help to&#xD;
      improve the quality of ECMO care.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>April 2015</start_date>
  <completion_date type="Actual">December 2016</completion_date>
  <primary_completion_date type="Actual">August 2016</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Perfused small vessel density</measure>
    <time_frame>At enrollment (within 12 hour after placement of extra-corporeal membrane oxygenation life support)</time_frame>
    <description>Perfused small vessel density measured by incident dark field video microscope</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Total small vessel density</measure>
    <time_frame>At Enrollment</time_frame>
    <description>Total small vessel density measured by incident dark field video microscope</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Endocan level</measure>
    <time_frame>At enrollment</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Microvascular flow index</measure>
    <time_frame>At enrollment</time_frame>
    <description>Microvascular flow index measured by incident dark field video microscope</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">48</enrollment>
  <condition>Heart Failure</condition>
  <condition>Respiratory Failure</condition>
  <arm_group>
    <arm_group_label>28-day Survival</arm_group_label>
    <description>survive for at least 28 days after placement of extra-corporeal membrane oxygenation life support</description>
  </arm_group>
  <arm_group>
    <arm_group_label>28-day Nonsurvival</arm_group_label>
    <description>not survive for 28 days after placement of extra-corporeal membrane oxygenation life support</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Extra-corporeal membrane oxygenation life support</intervention_name>
    <description>venoarterial extra-corporeal membrane oxygenation life support</description>
    <arm_group_label>28-day Nonsurvival</arm_group_label>
    <arm_group_label>28-day Survival</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients who require venoarterial extra-corporeal membrane oxygenation (ECMO) life support&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients who require venoarterial extra-corporeal membrane oxygenation (ECMO) life&#xD;
             support&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  who can not take an examination of sublingual microcirculation within 6 hours after&#xD;
             placement of venoarterial ECMO support&#xD;
&#xD;
          -  Non-native speakers&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>79 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Yu-Chang Yeh, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>National Taiwan University Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>National Taiwan University Hospital</name>
      <address>
        <city>Taipei</city>
        <zip>100</zip>
        <country>Taiwan</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Taiwan</country>
  </location_countries>
  <verification_date>December 2016</verification_date>
  <study_first_submitted>March 15, 2015</study_first_submitted>
  <study_first_submitted_qc>March 15, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 19, 2015</study_first_posted>
  <last_update_submitted>April 19, 2018</last_update_submitted>
  <last_update_submitted_qc>April 19, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 23, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Respiratory Insufficiency</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

